Melbourne · Pre-Seed–Series A · 1 people tracked
Investment thesis
Brandon BioCatalyst focuses on translating medical science from research into commercial ventures across the life sciences. Rather than acting purely as a capital provider, it uses a hands-on venture model, partnering with entrepreneurs to build and operate companies. Its interests span cancer, molecular bioscience, metabolic and musculoskeletal medicine, infection and immunity, and broader biotech and medtech innovations. Backed by a collaboration of superannuation funds, CSL, national and state governments, and medical research institutes, the fund aims to accelerate medical innovation and bring novel therapeutics and diagnostics to patients.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 5 of 10 portfolio companiesBiotech ×4Healthtech ×4Deep Tech ×2Digital Health ×2FemTech ×1Longevity ×1Medical Devices ×1
HQs:Australia×1United States×1
Investments · 10 tracked
founders shown can be your intro pathCommenced a Phase I safety study in patients with early Alzheimer's disease.
ENA Respiratory is a clinical-stage pharmaceutical company developing antiviral host defense enhancers intended to prevent severe complications from respiratory viral infections in at-risk, vulnerable populations.
BiotechHealthtech
Co-investorsStoic VCUniSeed Pty Ltd.
George Medicines is a spin-out from The George Institute for Global Health that develops single-pill combination therapies by formulating existing, established drugs into multi-mechanism treatments.
BiotechDigital Health
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)Casey Cunningham(Director)Leighton Read(Director)Bob Soh(Director)
Therapies for fibrotic and inflammatory diseases associated with diabetes complications
Co-investorsStoic VCBrandon Capital Partners
OncoRes Medical develops an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to give surgeons real-time assessment of tissue microstructure at a resolution comparable to histology.
Deep TechHealthtechMedical DevicesPerth, AU
Co-investorsRadar Ventures
Co-investorsBrandon Capital Partners
Clinical-stage biotech developing Q-122, an orally bioavailable small molecule for treating endocrine therapy-induced hot flashes in breast cancer patients.
Co-investorsStoic VC
Que Oncology develops non-hormonal therapies for moderate to severe vasomotor symptoms in postmenopausal women and in cancer patients undergoing hormone therapy.
BiotechFemTechHealthtech
Co-investorsStoic VC
Frequently asked questions
- How many investments has Brandon BioCatalyst made?
- Brandon BioCatalyst has 9 tracked investments.
- What stage does Brandon BioCatalyst invest at?
- Brandon BioCatalyst invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Brandon BioCatalyst focus on?
- Brandon BioCatalyst focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Brandon BioCatalyst located?
- Brandon BioCatalyst is headquartered in Melbourne, AU.
- Does Brandon BioCatalyst lead rounds?
- Yes, Brandon BioCatalyst leads investment rounds.
- Who does Brandon BioCatalyst co-invest with?
- Brandon BioCatalyst most often shares deals with Stoic VC, Brandon Capital Partners, Radar Ventures, among 3 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.
Crossroads Health Ventures is an early-stage venture firm investing in life sciences innovation, focused on U.S.-based companies and aligned with strategic limited partners.